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Abstract  
In response to the Office of Inspector General’s research report on atypical antipsychotic 
off label treatment of elderly dementia residents in long-term care, the Centers for 
Medicare and Medicaid Services developed a non-pharmacological intervention known 
as the Hand In Hand training tool.  This projects focus was on training the direct care 
nursing staff with the Hand In Hand tool and evaluating for decrease in behavior and 
psychological symptoms in their patients.  A retrospective chart review was utilized for 
the Minimum Data Sets tool Brief Interview of Mental Status (BIMS) and Mood 
interview.  Pre training and post training scores were analyzed using descriptive 
statistical paired sample t test.  No statistical significance was shown on the pre and post 
BIMS or Mood scores.  Six months of Pharmacy Review Summaries were collected and 
averaged for pre and post medication prescriptions for residents during six months of this 
project.  No increase was found on the administration of atypical antipsychotics during 
this period.   
Keywords: Dementia, Off-label atypical antipsychotics 
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CHAPTER I 
Introduction 
Non-Pharmacological Interventions Project: Treatment for Dementia 
A major concern to healthcare of the elderly is the use of off-label atypical 
antipsychotic medication to treat dementia.  Risks associated with atypical antipsychotic 
medications include confusion, sedation, postural hypotension, and increase in death 
(Casey, 2011; Shekelle et al., 2007).  Traditional medications for dementia are used and 
in some long-term facilities there are non-pharmacological treatments such as music and 
art therapy being used.  More rigorous research in non-pharmacological management of 
behaviors is needed to confirm their use in treatment of behavior and psychological 
symptoms in dementia (BPSD) (O’Neil et al., 2011).  
This capstone project focus was on a non-pharmacological intervention called 
Hand In Hand training for care givers of residents with dementia, and producing 
outcomes to show the need to reduce the use of atypical antipsychotic medications. The 
Centers for Medicare and Medicaid (CMS) developed the Hand In Hand modules in 2013 
to aid care givers in nursing centers with assessment and management of dementia 
behaviors (Centers for Medicare and Medicaid Services, 2013).  These modules 
emphasize person centered care, communication, meeting the resident’s needs, 
refocusing, and redirecting the resident during times of behavior and psychological 
symptoms of dementia. 
Dementia: what is it and what are the effects on people?  According to the 
National Institute of Health it is a disease that has many symptoms (National Institute of 
Health, 2013).  Dementia affects cognitive, emotional, behavioral functions, and even the 
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personality of those with the disorder.  Memory, language, and problem solving skills can 
all be affected.  Diseases of Alzheimer’s or Huntington’s can cause dementia and also 
disorders of deficiencies in nutrition, tumors of the brain, and even medication reactions.   
Residents can demonstrate symptoms of wandering, agitation, aggression, pacing, 
irritability, and sleep disturbances.  These can be present in the neuropsychiatric 
symptoms of dementia (Ballard & Corbett, 2010).      
The Hand In Hand training modules, developed by Centers for Medicare and 
Medicaid Services (CMS), is for improving the management of behaviors in dementia 
patients.  The goal is to decrease the potential risk of decline and negative side effects 
from antipsychotic medications in the elderly with dementia through training of staff 
emphasizing person-centered care.  This project implemented the Hand In Hand training 
and gathered data to analyze outcomes of behavior and medication regimes post training. 
Problem Statement 
Powerful antipsychotic medications have been shown to cause serious side effects 
in the elderly and increase the risk of death (Shekelle et al., 2007).  Despite these 
warnings many nursing care centers, where elderly residents with dementia reside, 
continue to treat dementia residents with atypical antipsychotic medications.  There are 
few high grade level research studies to support the use of non-pharmacological clinical 
treatments for dementia, which has led to increased management of behavior and 
psychological symptoms in dementia through off-label atypical antipsychotics. 
Justification of Project 
From January 1 through June 30 of 2007, 14% or 2.1million elderly residents in 
nursing homes had at least one claim for Medicare reimbursement of an atypical 
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antipsychotic at a cost of 309,028,317 dollars (Appendix A).  Of those claims, 83% were 
for off-label use and 88% were being used in conditions against the Food and Drug 
Administration (FDA) boxed warning (Appendix B).  These erroneous claims totaled to 
$116 million (Appendix C) (Office of Inspector General (OIG), 2011).  A total of 22% 
were administered against CMS standards for treatment of unnecessary drugs (Appendix 
D) (OIG, 2011).  The costs in both lives and dollars to the health care systems (Medicare, 
Medicaid, and Insurance) are staggering (OIG, 2011).   
As the baby boomer generation, those born from 1946 through 1964, continues to 
age and join the healthcare system, this burden will increase by 76 million boomers 
(Blumenthal, 2011).  The trend in nursing homes is to favor the use of these drugs for 
dementia treatment.  Researchers have found that prescribing rates were directly linked to 
residents’ characteristics (36%), characteristics of the facility (23%), and 81% to the 
nursing home culture of prescribing (Huybrechts, Rothman, & Brookhart, 2012).  
Staffing issues, problems with medication reconciliation, and family wishes also are 
significant barriers to changes in treatment of dementia in the elderly.  Resident quality of 
life and independence helps to lessen the caregivers burden (Kurt, 2011).  Stricter 
monitoring of these drugs, assessments of side effects, and use of non-pharmacological 
interventions can reduce risk to the patients (Lindsey, 2009).   
Medicare Claims 
Despite the evidence of the dangers of off-label atypical antipsychotic medication 
use with the elderly, these drugs continue to be prescribed for elderly dementia residents 
within nursing facilities.  The claims for Medicare reimbursement produce evidence of 
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the use of these drugs for behavioral and psychological treatments for diagnoses against 
recommended use. 
The Department of Health and Human Services (DHHS) Office of Inspector 
General’s (OIG) report of May 2011 evaluated claims to Medicare concerning off -label 
atypical antipsychotic drugs for nursing home residents 65 years or older during January 
1-June 30, 2007 (OIG, 2011).  The OIG’s concerns for increase in off label atypical 
antipsychotic drug claims and their costs prompted them to ask the question whether 
these medications were being used appropriately.  Findings revealed off label use of these 
drugs were being prescribed for treatment of dementia and not necessarily for 
recommended use according to FDA.  
Atypical Antipsychotics 
Currently only eight antipsychotic medications are approved for treatment of 
behaviors associated with schizophrenia and bipolar disorder (OIG, 2011).  Part of the 
regulation of the Centers for Medicare and Medicaid (CMS) provides protection of 
residents from the use of drugs not warranted and the length and dosage amounts given.  
Medicare uses the Minimum Data Sets (MDS) part B & D to identify the medication 
claims.  This instrument is done at least every three months on each resident (OIG, 2011).     
This extensive review of Medicare claims included International Classification of 
Diseases (ICD-9) codes for claims.  Nursing home inpatient and skilled nursing home 
data was compared over a six month period for transfers to other facilities.   The 
Prescription Drug Event (PDE) program data was examined, due to their summary not 
individual dosages.  Individual nursing home documentation included pharmacy review 
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records, admission records, resident care plans, nurse’s notes, consultations notes from 
behavioral monitoring, and MDS assessments. 
The statistical reports are from the Office of  Inspector General’s (2011) report on 
off-label atypical antipsychotics for the Department of Health and Human Services.  
(Appendix A-D)   Findings indicated that 14% of the nursing home elderly had Medicare 
claims for at least one atypical antipsychotic.  Of those claims surveyed, 83% were for 
off-label use and 88% were prescribed for conditions listed in the FDA warning box.  
Erroneous claims were 51%, at a cost of $116 million.  The atypical antipsychotics, 22%, 
were given despite the standards that the CMS considers as unnecessary drugs.   
Although only eight drugs are approved, physicians often prescribe off label and 
the practice is permitted.  The Department of Veterans Affairs found in 2009 that 60.2% 
of these atypical anti psychological drugs being prescribed had no record of the diagnosis 
for which it was being used. 
Despite the CMS guidelines for using these drugs, the medical criteria for 
accepted use were not applied.  The CMS guidelines also required quality and safety 
standards for nursing facilities.  One such requirement is freedom from drugs that are not 
necessary. According to the standards set by CMS and drug criteria, these off-label drugs 
do not qualify for compensation for treatment.  Findings revealed that off- label atypical 
antipsychotic drugs were without adequate monitoring and were shown to be lacking any 
indication of their use (OIG, 2011).  
This report reviewed over eight million medication claims: of the claims 
reviewed, 1,678,874 met criteria.  A sample size of 700 was included in the report.  
Office of Inspector General admitted limitations to the report including length of the 
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study, pharmacy did not provide the drug information, and clinical staff was not a part of 
the evaluation.  
Risks 
            In 2007, The Agency for Healthcare Research and Quality (AHRQ) studied and 
concluded that these off-label drugs increase risk of death for dementia residents.  Why 
are these drugs so dangerous in the elderly?  The answer lies within the changes to their 
bodies’ systems.  In people 65 or older, the systems such as cardiovascular, liver, and 
kidney functions show the most profound effect from the impact of these drugs.  The 
multi-organ inability to function at full capacity makes them more vulnerable and the 
drugs upset the balance of their health.  Due to sensitivity in the brain’s receptor sites and 
decreases in function of the brain, there are serious outcomes from use of the 
benzodiazepines, antidepressants, and antipsychotics. 
These drugs can actually increase confusion, sedation, and postural hypotension 
in the elderly.  Older resident often have poly-pharmacy medication regimens which also 
increases risk and adverse responses to these types of medications.  The imbalance of 
their homeostasis and cognitive impairment further complicates therapeutic effects of 
these types of medications.  Drugs often lose therapeutic effect from increasing dosages 
leading to toxic effects (Casey, 2011).  In the OIG (2011) report, the failure of monitoring 
the drugs for reduction was significant to the safety issues for prescribing.  Non-
pharmacological interventions are the alternative means when dealing with the behaviors, 
as recommended by the OIG (2011) report. 
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Purpose 
The purpose of this capstone project’s focus was on training direct care staff to 
utilize non-pharmacological interventions in management of the elderly with dementia in 
long term care.  The goal was reduction in behavioral and psychological symptoms and 
potentially to illustrate the need to decrease usage of atypical antipsychotic drugs. 
Project Question 
Can non-pharmacological intervention training of direct care staff decrease 
behavior and psychological symptoms in elderly dementia residents and potentially 
demonstrate a need for reduction in atypical antipsychotic medication use? 
Definition of Terms 
The following are definitions of terms referred to in this capstone project paper.  
The terms are used to define the symptomatic disorder of dementia and the descriptive 
term of the classification of medications that the elderly with dementia are being 
prescribed. 
 Dementia: not specifically a disease but symptoms from many disorders 
like Alzheimer’s or brain tumors that affect the mind, behavior, 
personality, or emotional stability.  It can affect memory, cause emotional 
outbursts and agitation, and change personality (Dictionary.com). 
 Off-label atypical antipsychotic: second generation drugs that are given 
for other disorders not specific for the diagnosis for schizophrenia or 
bipolar disorder (Kohen, Lester & Lam 2010; Shekelle, et al., 2007). 
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Summary 
The capstone project addressed the use of atypical antipsychotics for dementia 
and attempted to add support for the use of non-pharmacology intervention.  The training 
implemented the Hand In Hand training to affect behavior and endeavored to demonstrate 
the need for non-pharmacological interventions in the treatment of dementia in the 
elderly.   
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CHAPTER II 
Research Based Evidence 
Effects of atypical antipsychotics on the elderly can be a serious risk.  The 
Agency for Healthcare Research and Quality (AHRQ) compared efficacy of the off label 
atypical antipsychotics in their 2007 report (Shekelle et al., 2007).  In this executive 
summary of findings, the risks were cardiovascular, increase risk of death, and extra 
pyramidal symptoms.  Studies included 15 placebo-controlled trials, and a large head to 
head placebo controlled trial.  The AHRQ concluded that the risk of death was small but 
so was the benefit of the off label atypical antipsychotic drugs and felt more information 
was needed about the death risks and found that conventional or typical antipsychotic 
drugs were potentially more risky.  The findings indicated not enough high level research 
had been done to prove efficacy of atypical antipsychotics, and until evidence was 
available no one could conclude safety and efficacy of their use.  These second 
generation antipsychotic drugs continued to be prescribed despite the questions of 
efficacy and safety. 
Review of Literature 
A review of the literature by Kohen et al. (2010) of the efficacy and safety of one 
of the treatments of a second generation antipsychotic drug aripiprazole (Abilify), had 
little evidence to support use of the drug but did not discount Abilify. The suggestion 
from the review was that Abilify may be better than other drugs due to its metabolic 
benefits.  The delusions, psychosis, and hallucinations accompanying the drug were 
considered as related to dementia.  In three 10 week studies of 487 nursing home 
residents, there were no significant outcomes between the treatment with Abilify and 
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placebo with 256 residents.  Kohen et al. (2010) conclusions felt that second generation 
antipsychotics are greater risks to the elderly and not treating in mild dementia might be a 
practical choice.  Additional comparative studies involving non-pharmacological 
interventions and atypical antipsychotics would provide possible options for treating the 
mild dementia patient.  There is not enough research evidence to decrease the use of these 
drugs in dementia or treat mild dementia effectively.  Warning labels from the FDA have 
not prompted a reduction in the use of the off-label atypical antipsychotics.  
Safety and Efficacy 
Kim, Brown, Ding, Kiel and Berry (2011) questioned safety in other medications 
commonly given to residents with dementia and Alzheimer’s dementia such as 
cholinesterase inhibitors and Memantine.  A RCT meta-analysis was conducted to 
examine the safety and fall rates associated with the treatments using both drugs.  This 
study considered the impact of falls, fractures related to falls, syncopial incidents, and 
injuries that were accidental (Kim et al., 2011).  Of the 156, RCT considered only 54 
were eligible due to lack of data on adverse events related to falls.  Findings indicated 
that cholinastrase did increase risk of syncope, but no effect related to falls, fracture, or 
accidents.  Memantine actually had beneficial effects on fractures, a surprising finding.  
The findings were not conclusive due to under reporting and decreased outcome events 
available.  The study only looked at two common drugs administered to dementia 
residents and their side effects.  More research was needed to include the eight most 
prescribed atypical antipsychotics and their effects on the elderly.        
Maher et al. (2011) conducted a systematic review and meta-analysis to address 
the efficacy of off- label use of atypical antipsychotics for dementia.  The review 
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revealed that from 1995 to 2008, off label atypical antipsychotics doubled in prescribing 
rates from 6.2 million to 14.8 million. The eight drugs investigated were aripiprazole, 
asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and 
ziprasidone.   The systematic review revealed that death risks increased by 3.5% with the 
use of these drugs compared to 2.3% in placebo.  With olanzapine and risperidone, there 
was greater occurrence of cardiovascular, vasodilatation, and edema symptoms.  
Risperidone had significant signs and symptoms for increased stroke risks.  Health risks 
were increased incident of diabetes, sedation, fatigue, extra pyramidal symptoms, urinary 
tract infections, decreased cognitive functions, orthostatic dizziness, confusion seizures 
and headaches.  Overall, of the four large studies done, the risk of death increased with 
conventional antipsychotics: two smaller studies showed increased with both types of 
drugs, and the findings of increased mortality were found for both classifications of 
drugs. A small but statistically significant benefit for treatment in behaviors in dementia 
patients was found in aripiprazole, olanzapine, and risperidone but harmful effects of the 
drugs were also statistically significant in the elderly. Maher et al. (2011) concluded that 
off-label atypical antipsychotic drug use in the elderly with dementia is associated with 
adverse outcomes and are statistically significant in increasing risk of death, showing that 
use of these drugs and adverse effects are related.  Decisive research on the atypical 
antipsychotics and their serious risks to the elderly with dementia was now evident.   
Despite warnings from the FDA and mounting evidence from researchers prescribing of 
these drugs to dementia residents increased.  
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Evidence of Use 
Evidence was available that the off-label atypical antipsychotic drugs were being 
widely used for dementia in the elderly.  The National Veterans Administration (VA) set 
out to discover how many elderly veterans were receiving these drugs for dementia.  A 
multivariate logistic regression method was done on the VA database looking for at least 
one prescription of off label use from 2006 until 2007.  The study of off-label use of 
antipsychotic drug use in the VA system revealed evidence, like many other care settings, 
that the elderly with dementia are commonly prescribed these drugs (Leslie, Mohamed, & 
Rosenheck, 2009).  Seven drugs were examined in this study: aripiprazole, clozapine, 
olanzapine, quetiapine, risperidone, and ziprasidone.  Diagnosis was considered with 
schizophrenia and bi-polar being excluded.  The sample size was 279,778; of that number 
60.2% (168,442) had no diagnosis to be prescribed the drugs.  Prescribing for post-
traumatic stress syndrome (PTSD) was over 40%: 39.5% was for minor depression, 
23.4% received the drugs for major depression, 20% for anxiety:  20% for alcohol and 
15.1% for drug dependency.  The study acknowledged the fact that the ratios of patients 
in groups were over 100% and the extent of the co-morbidities within the patient 
population.   In quetropine use, the largest group receiving the drug was organic brain 
syndrome and Alzheimer’s dementia.  If the veteran had PTSD, psychosis or organic 
brain syndrome or Alzheimer’s, their odds for being prescribed these drugs increased 
(Leslie et al., 2009).  Although indication for use of these drugs in dementia was absent, 
prescribing rates continued to increase.  The OIG (2011) report was now verified by the 
VA report that nursing home dementia residents have been administered these atypical 
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antipsychotics and the prescribing rates have varied across the country regardless of 
indication of use.   
 A systematic review meta-analysis conducted by Chen et al. (2010) supported the 
evidence of variation rates in the nursing homes in the United States (U.S.).  Data was 
collected from a national database of MDS forms and prescription data records.  The 
forms were collected from 2005 through 2006.  Sample size was 16,586 from 1257 
nursing homes and pharmacy claims were 66,181.  In 2006, more than 29% of nursing 
home residents received at least one antipsychotic drug with 32% having no indication 
for use (Chen et al., 2010).  When facilities have a high rate of prescribing, it was found 
that the resident would be 1.37 times more likely to receive these drugs than those 
residents in low prescribing facilities.  Race was also an indicator of prescribing rates and 
confirmed in the VA research.  Chen et al. (2010) found the white race was 11% more 
likely to get these drugs than blacks.  Of those without psychosis, whites were 30% more 
likely than blacks and 22% more likely than Hispanics.   Dual eligible patients, those 
with Medicare and Medicaid, were also more likely to receive antipsychotic drugs.  Once 
again the conclusion of this study supported evidence of variation of prescribing in 
nursing homes related to previous prescribing rates and race.   
In 2012, the Beers Criteria for potentially inappropriate medications (PIM) for 
nursing home residents was revised by an expert panel of geriatricians and 
pharmcotherapists (American Geriatrics Society, 2012).  The systematic review and 
evidence grading of classification of PIM’s was to update the previous Beers Criteria.  
This update was considered necessary based on the evidence that despite warnings these 
drugs continued to be first line treatment for the elderly.  The drugs were classified in 
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three categories: those medications that were potentially inappropriate for use, those 
drugs which exacerbated existing conditions and those that needed caution when 
prescribing for the older adult.  The new Beers Criteria linked with the American 
Geriatric Society allows for best practice and clearer system updates from experts to 
guide policy, research, and clinical practice (American Geriatric Society, 2012).  A total 
of 53 medications are included in the updated Beers Criteria, under the three categories of 
PIM. The Beers Criteria is considered a clinical guide to drugs that are more harmful than 
beneficial to the older adult. 
Regardless of the warnings, neurologists have many questions about the OIG 
report and the overuse of these drugs.   These off label antipsychotic drug use are seen as 
either a means of restraint or a way to save money by using cheaper non-conventional 
medications (Samson, 2011).  Dr. Louis Cooper, professor of neurology at Harvard 
Medical School, sees these drugs as medical straightjackets and is largely unmonitored 
once given.  Dr. Cooper felt a lack of adequate funding to manage the problem residents 
in nursing homes was a major rationale in using the atypical antipsychotic drugs 
(Samson, 2011).  Dr. Nair, chief of Neurology at the Alzheimer’s Medical Center, 
thought the data was incomplete and felt conventional drugs were more harmful.  He felt 
this was a cost issue, and since no drug has been approved for behavior in dementia, the 
report was generated to cut costs.  Dr. Nair felt these drugs should be used when non- 
pharmacological attempts have failed and the behavior becomes unmanageable (Samson, 
2011).  
Although there was a divide on the use of these drugs and how they are 
prescribed, one issue remained the same: there was a need to have recommended 
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treatments that are safe and effective when treating the elderly with dementia.  With such 
differing opinions and lack of comparative studies for pharmacological and non-
pharmacological treatments, what is the recommended treatment for elderly residents 
with dementia? 
Treatment Recommendations 
In 2006, the VA Office of Geriatrics and Extended Care (OGEC) directed a 
committee to ask key questions concerning dementia care for the veterans related to non-
pharmacological treatment in behaviors compared to pharmacological treatments (O’Neil 
et al., 2011).  Three key questions were considered: the effectiveness, safety, and costs of 
non-pharmacological treatment in dementia versus pharmacological treatment. (O’Neil et 
al., 2011).   Studies included cognitive, exercise, animal assisted, massage, music, animal 
assisted therapy, memory, acupuncture, aromatherapy, and behavioral management 
interventions were all considered.  Other areas reviewed were related to techniques for 
prevention of wandering, agitation, and inappropriate sexual behaviors using barriers, 
environmental modifying, and distraction.  Conclusions were considered varied as to 
effectiveness of treatment of behavior and psychological symptoms of dementia (BPSD). 
In the cognitive area, validation therapy showed some significance compared with other 
therapies.  Aromatherapy showed some promise in decreasing agitation: no differences 
were found for exercise, massage, or acupuncture and only mixed reviews for light 
therapies.  No evidence on the environmental modification and unclear evidence in the 
barrier or other treatments for behaviors management. Very little information was found 
concerning cost related research.  Overall this review suggested more rigorous evidence 
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is needed using blinding methods and management of treatments being standardized to 
produce consistent results.   
 Khan and Curtice (2011) conducted a pilot project in the United Kingdom to 
produce evidence for non-pharmacological treatment to be used initially.  It was 
conducted in four care homes across the nation.  Sessions were held for six months and 
each home had six sessions conducted.  Training was done to prepare caregivers and staff 
with knowledge to intervene with non-pharmacological techniques of relaxation, 
distraction, nostalgic thoughts and art, music therapy with person centered focus.  
Monitoring also occurred with all psychotropic medication therapy.   
Significant findings were the need for a team approach, effective training was essential in 
dealing with BPSD for all staff and avoidance of an easy quick solution using 
psychotropic drugs to manage BPSD (Khan  & Curtice, 2011).   Lindsey (2009) revealed 
in her systematic review the importance of knowledge and a collaborative relationship 
between nurses and physicians.  Person centered care is part of the emphasis placed on 
nurses and all caregivers to improve quality and safety for the patients with dementia. 
Person-Centered Care 
The need to individualize care is part of person-centered care model that has been 
instituted in most healthcare settings.  Suhonen, Alikleemola, and Katajisto (2010) 
descriptive design study considered individualized care with the goal to describe the 
perceptions of nursing in the long term care and long term in-patient wards.  The 
Individualized Care Scale-Nurse was used to collect data from 283 nurses.  In the clinical 
situations, nurses felt they were using individualized treatment and care of their elderly 
residents.  They recognized that individual control of decisions was lacking in and during 
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nursing activities.  Although nurses perceived they provided individual care, generally 
this was not evident in the assessment of practice overall.  This study did produce 
improved results on individualized care from nurses compared to previous studies.  In the 
treatment of the elder dementia resident, individualized person-centered care given by 
knowledgeable nurses is imperative to monitoring and decreasing unnecessary 
antipsychotic drug use for the improvement of their safety and quality of life.   
 In Zee and Burkett’s (2008) critically appraised paper of behavior management, 
they proposed that once a person begins into dementia behavioral problems, it is usually 
two years to nursing home placement.  Behavior management then becomes an essential 
part of treatment.  One of the Office of Inspector General’s (2011) recommendations was 
alternative methods for compliance, which included education and training for nursing 
home staff in dealing with behaviors in dementia.   Environment plays a key part in 
decreasing behaviors (Zee & Burkett, 2008).  These behaviors can include pacing, 
wandering, agitation, aggression, and depression.  Some of the suggestions to decrease 
these behaviors include a reduction of choice, various cues, and redirecting.  Non-
confrontational management of behaviors is important and always with resident safety in 
mind.  In conclusion Zee and Burkett (2008) emphasize treating underlying needs of the 
resident, if needed treating BPSD with low dose antipsychotic drugs and only with 
atypical antipsychotics when benefits are clearly evident and there are few side effects. 
Ballard and Corbett (2010) suggested that first line treatment should be non-
pharmacological interventions.  This systematic review considered meta-analysis and 
cohort studies previously done.  When compared to reviews on non-pharmacological 
studies, systematic reviews of 162 studies and RCT were evaluated.  Ballard and Corbett 
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(2010) found that person-centered care, enjoyable activitie,s and exercise decreased 
BPSD.  Treatment with low dose atypical antipsychotics when needed has not been ruled 
out as a treatment but is not suggested as a first line treatment.  It is the project 
administrator’s opinion that non-pharmacological interventions are the alternative 
interventions when dealing with the behaviors, as recommended by the OIG (2011) 
report.          
Cognitive Stimulation Therapy 
Aguirre et al. (2012) randomized control study of Cognitive Stimulation Therapy 
(CST), followed 272 dementia participants for seven weeks to determine the reasons that 
might predict their response to the CST. The residents were from multiple settings 
including care homes, day centers, and mental health centers located within the 
communities.  The participants were randomly selected into two groups, decreasing the 
intra class correlation, with both groups receiving the CST.  The interaction included 
exciting language interchanges, reminiscing, thinking sessions with points of references, 
and with a person-centered focus.  Quality of life, cognition, behavioral disturbances, and 
activities of daily living (ADL) were all measured.   Results for the study revealed when 
compared to previous RCT of cognitive stimulation therapy, this study showed 
significant changes in scoring.  Quality of life indicator scores increased after CST.  
Significance of this study could lie in the person-centered approach, as Lindsey (2009) 
review stated.  An unexpected finding was how 80 years old and older had scores that 
showed positive effect from cognitive stimulation therapy.  Reflections from researchers 
concerning the age group related to overall lack of stimulation compared to those 
younger and changes that occur with age, not dementia related, have to be considered.      
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Exercise 
A non-pharmacological intervention that has shown some promise is exercise.  At 
the time of publication, Cerga-Pashoi et al. (2010) was conducting an ongoing study 
implementing incremental walking exercise with 146 participants.  Two randomized 
groups participated, one received the walking and one received treatment as usual.  The 
program is for 6-12 week periods, with a 20-30 minute walking regime with a qualified 
exercise therapist.  Measures were taken for physiological and psychological effects at 
the 6 and 12 week timeframes.  Zee and Burkett (2008) found that indications are that 
exercise is neuro-protective for reducing risk in dementia and has shown promise in 
dementia care.  The NeuroPsychiatric Inventory tool (NPI), developed for assessment of 
BPSD is being used in the assessment of areas of quality of life, usage of psychotropic 
medications , placement into care facility, level of transience of life, and burden that the 
care givers felt (American Psychological Association, 2013). This study, if outcomes are 
positive, would add to the evidence, using a valid and standardized tool.  The larger 
systematic reviews felt previous trials were deficient in using valid tools. 
Aromatherapy        
The non-pharmacological intervention aromatherapy has shown some 
effectiveness with dementia in the large systematic review by the VA (O’Neil et al., 
2011) and the review by Ballard & Corbett (2010).  In both reviews, aromatherapy had 
positive effects when treating agitation in dementia.  Bidewell and Chang’s (2011) 
systematic review on dementia treatments in residential care included aromatherapy.  
Agitation was defined as an unmet need and relationship of the resident to the 
environment, whether it was an internal or external stimuli.  There were 241 studies out 
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of 3,100 that met criteria.  Lavender was found in one review to also have positive effects 
on BPSD.  However, similar to other reviews, only one study was felt to be rigorous 
enough to produce evidence to show a favorable response when using aromatherapy for 
agitation.   Bidewell and Chang (2011) also considered aromatherapy as a 
pharmacological treatment, which was an unexpected conclusion.  Overall, the 
conclusion from the systematic review was that no one treatment method was found to be 
effective and the high grade level studies remain scarce.  As with many other non- 
pharmacological studies, the trials are not considered high grade to produce the evidence 
needed. 
Music       
Music therapy has been used as a non-pharmacological intervention with 
dementia residents.  In the previous VA systematic review (O’Neil et al., 2011) music 
therapy had questionable results.  Cook, Moyle, Shum, Harrison, and Murfield (2010) 
randomized cross over design study questioned music and the validity of treatment for 
agitation in dementia and to improve emotional and quality of life. Participants were 
placed in music or reading groups and then switched at half way point.  The study was 
conducted in two mixed long term care facilities and researchers were blinded to patient’s 
characteristics.  The analysis of the study revealed no statistical significance in either arm 
of the study to decreasing agitation in the residents.  There was an increase in verbal 
aggression and researchers felt that the therapies helped patients find their voice again.   
Nevertheless, the non-pharmacological intervention had a significant result in that both 
interventions caused an increase of verbalization of residents. 
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Communication 
  Communication is a powerful tool that is used every day by all people and 
effective communication is essential to all who provide care to others.  Williams, 
Herman, Gajewski, and Wilson (2009) conducted an observational study to address the 
use of elderspeak and its effect on dementia residents.  Elderspeak, defined as 
infantilizing communication (baby talk), is used during ADL’s with the dementia 
residents often by the nursing staff giving care (Williams et al., 2009).  The study 
examined the use of elderspeak and the correlation to resistance to care (RTC) compared 
to normal talk with dementia residents.  RTC was defined as aggression, vocal eruptions, 
and pulling away.  The study design was analyzed using psycholinguistic, observational, 
and behavioral methods.  Video and audio recordings were conducted on 80 interactions 
between staff and residents during ADL’s. Measurements were made using the 
Systematic Analysis of Language Transcripts (SALT) computer program and the 
Resistiveness to Care Scale (RTCS).  Conclusions were that a temporal relationship does 
exist between elder speak and increase RTC behavior in comparison to normal talk and 
RTC.  
Recommendations have been made to include non-pharmacological treatments for 
patients with early stage/mild to moderate dementias.  Burgener, Buettner, Beattie, and 
Rose (2009) consensus report supports community based treatment modalities, using non 
pharmacological interventions, to treat dementia on a national level.  The report was 
based on 150 research articles using non-pharmacological interventions in six areas.  The 
areas included support early in the disease, cognitive interventions, and exercise 
programs that involve writing and art, promotion of health, program utilizing sleep, and 
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hygiene aid.  It was determined in the report that increased access to community based 
interventions would decrease the stigma that society places on dementia, reduce the over 
medication of these people, and help people to achieve more normalized lives.   Some 
studies suggested that these interventions can slow cell destruction and maintains some 
neural abilities.  Giving the long term programs accessibility to help maintain dementia 
patients in the home improves the quality of life.  Identifying the caregivers as essential 
partakers of the therapies also would increase positive outcomes.  Other suggestions in 
this report were the application of evidence based protocols for clinical practice for non-
pharmacological interventions to be a part of treatment for early stage dementia. 
Goal 
The American Health Care Association (AHCA) and the National Center for 
Assisted Living (NCAL) started a quality initiative in 2012 to improve the quality of care 
in skilled nursing homes and assisted living communities across the United States 
(American Health Care Association & National Center for Assisted Living, 2013).  These 
goals included the reduction of off-label antipsychotics by 15% nationwide.  This quality 
initiative was in line with the Inspector General’s report, Department of Health and 
Human Service, the Senate Committee on Aging, and CMS goal of quality of life issue 
for residents and families.  The Hand-in-Hand project attempted to produce outcomes to 
support the use of non-pharmacological interventions in treatment of dementia (American 
Health Care Association & National Center for Assisted Living, 2013). 
Literature Gaps 
Literature gaps were in the non-pharmacological studies, studies being conducted 
did not produce rigorous high grade evidence to support its use in clinical treatment.  
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Many studies were of qualitative design and were not random controlled trials that 
produced enough empirical data.  A major gap in the literature was the cost comparison 
between using pharmacological or non-pharmacological interventions to treat dementia.  
Pharmacological costs were available but very few, if any, studies were mentioned in the 
literature on actual costs for non-pharmacological treatments. 
Strengths and Limitations of Literature 
Strength of the literature for this review was the amount of data from systematic 
reviews and the multiple databases used for the research.  Multiple databases used for 
literature including Pub Med, Cumulative Index to Nursing and Allied Health 
(CINAHL), PsycInfo, Cochran Database of Review of Effectiveness  (DARE), Cochrane 
Central Register of Controlled Trials (CENTRAL) and MEDLINE.  Reputable 
governmental and private agencies conducted many of the reviews, especially the 
pharmacological reviews.  Several of the studies were large studies with large samples 
with many levels of evidence. 
Limitations in the literature were heavily weighed on the non-pharmacological 
research.  Many of the reviews spoke of the lack of high grade evidence, problems with 
the scientific method of the studies and an overall lack in the literature of studies being 
conducted or evidence available to support non-pharmacological interventions in the 
treatment of dementia.   
Theoretical Framework 
The conceptual framework for this project is Betty Neuman’s Care Systems 
Model that is based on relationships of stress, response to the stress and constructs a new 
system to deal with the stressors (Neuman Systems Model, 2013).  The system is 
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considered universal in its design and adaptable in many ways.  Neuman’s design is 
centered on the premise that three lines of resistance: one representing the internal 
factors, normal line helping the patient maintain equilibrium, and a flexible one to help 
quickly change and adapt (Neuman Systems Model, 2013).  In the theory, the nurse’s 
interventions are involved in prevention.  These preventions are primary, secondary, and 
tertiary.  Normal lines preventions help protect, secondary preventions give strength to 
the internal lines, helping the reactions and resistance to stressors.  Tertiary helps the 
patient to adapt, become more constant and return to a state of wellness (Neuman 
Systems Model, 2013).  This capstone project used the primary prevention by using non-
pharmacological intervention for management of stressors.  By using communication and 
distraction methods the internal lines that react to stress can be managed by staff, 
utilizing the secondary prevention method in Neuman’s theory.  In the tertiary level of 
the project, consistent reinforcement of the non-pharmacological interventions help the 
resident adapt, maintain and return to their individualized equilibrium. 
Please refer to Figure 1 for Neuman’s Care Systems Model. 
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Figure 1.  Neuman’s Care System Model 
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Summary 
  Current literature has large studies and multi-level grade research in the 
pharmacological treatment of dementia with antipsychotics.   Atypical antipsychotic 
drugs should be limited, closely monitored, and discontinued when possible when 
associated with treatment for dementia in the elderly.  Costs in dollars and quality of lives 
will have a far-reaching impact on society.  One consideration in effective treatment of 
BPSD is by non-pharmacological interventions.  The challenge today is to demonstrate 
positive outcomes using non-pharmacological interventions and generate data for 
potential savings in dollars and lives. 
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CHAPTER III 
Project Description 
Project Implementation 
The capstone project included a retrospective chart review on the antipsychotic 
drug use in the long-term care facility.  Information from the executive summary of 
consultant pharmacists report on tracking psychoactive and hypnotic drug utilization was 
obtained.  This report is compiled monthly and three consecutive months were used for 
needs data.  The executive summary also used post project implementation to determine 
any changes in medication orders. 
A Brief Interview of Mental Status (BIMS) is completed on every new admission 
into the nursing facility at five days, 15 days, at 30 days, and again at 90 days.  BIMS is 
completed electronically on all residents and also by exception, when changes occur in 
behavior.  The BIMS test is a 15 point measure of both memory and orientation (Chodosh 
et al., 2008).  Data was collected at the beginning of the project from the BIMS on the 
above mentioned areas.   Previous BIMS data provided a baseline to analyze any changes 
in the areas of cognition and mood after implementation of the training in Hand In Hand. 
Data was compared on all new admissions prior to training and within the 90 day period 
following staff training. 
The Center for Medicare and Medicaid Services (CMS) (2013) has recently made 
available Hand In Hand training modules to all nursing homes to emphasize person-
centered care and prevention of abuse in dementia persons (CMS, 2013).   The Hand In 
Hand modules are focused on the principles of maintaining a process that includes the 
ability of the care giver to listen, test, reevaluate, change, and adapt their methods and 
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organization style to de-institutionalize the nursing home environment (CMS, 2013).   
Emphasis is placed being where the resident is, listening skills, redirecting behaviors, 
recognizing needs, and adapting the care to meet the resident’s needs.  The Hand In Hand 
was developed for primary caregiver training but CMS is suggesting that all personnel 
take part in the training.  In this training, personnel within the facility that have 
interaction with residents with dementia received the training.  Hand In Hand training 
session are divided into six one-hour sessions with DVD scenarios and a debrief session 
afterwards.  Administration assigned staff during several two-hour sessions throughout 
the day to attend.  Training took place over a two week period until all scheduled direct 
care staff completed a session.  Self-evaluations were included in post training as part of 
the modules.  
Data was collected on the residents’ Brief Interview of Mental Status (BIMS) and 
executive pharmacy summaries for the following three months.  Resident records 
including BIMS, pharmacy reviews were also evaluated before and after the training was 
completed.  Statistical data was analyzed including demographics, cognitive status, and 
mood from the BIMS. The BIMS tool is considered to be a good tool for cognitive 
assessment and accurate in identifying impairments in cognition (Chodesh et al., 2008; 
Tucker, 2013).  Pharmacy records were analyzed before and after for change in 
medication treatments.  
Setting 
The setting is in a long-term rehabilitation nursing center in the eastern United 
States.  The facility is corporate owned and has approximately 130 Medicare and 
Medicaid funded beds and 20 private pay beds available.  Long term stays and short term 
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rehabilitation services are delivered in the facility.  It serves a community of 
approximately 270,000 people not including rural areas within close proximity. 
Sample 
The sample size for chart reviews was fifty (N=50) residents that were being 
treated with atypical antipsychotics or other sedative/hypnotic medications.  The sample 
size did change at implementation of the capstone project, due to new admissions, 
discharges and mortality rates. 
Project Design 
Phase I    
This project began with the chart review of data from the Brief Interview of 
Mental Status and pharmacy review records for baseline data.  Implementations of the 
Hand In Hand training modules, in the nursing facility, were then scheduled.   
Stakeholders are residents, family members, staff, providers, and owners of the facility.  
The goal was to train 80% of staff including nursing, nursing assistants, administration, 
and ancillary staff.  Six Hand In Hand training modules were conducted over a three day 
period at the beginning of October, 2013.  Modules are self-contained with debriefing 
sessions and self-evaluation for the participants.  
Administrative staff ensured all patient information was de-identified from the 
facility for the capstone project.  A numerical code was implemented to represent each 
resident in the project.  Brief Interview of Mental Status (BIMS) was used for data 
collection on cognitive and mood data, as well as, monthly Pharmacy Review Summaries 
used to analyze the atypical antipsychotic drugs given monthly.   
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Phase II: Data Collection and Analysis 
Phase II was done post training, data from Brief Interview of Mental Status 
(BIMS) evaluations and pharmacy executive summaries were obtained at mid-January, 
2014.  Data was collected from the cognitive and mood elements of the BIMS.   
Pharmacy Review Summaries were collected from the previous three months, before 
training and for the three months post training.  Statistical analysis using Statistical 
Package for the Social Sciences (SPSS) version 22 software was used to evaluate the 
data. 
Phase III: Defense 
Project findings were written for dissemination and an oral presentation given. 
Protection of Human Subjects 
 All records of nursing facility, residents Brief Interview of Mental Status, and 
Pharmacy Reviews were de-identified and Institutional Review Board approval was 
obtained prior to implementation of the project. 
Instruments 
The Brief Interview of Mental Status (BIMS), Mood data tool, Pharmacy Review 
Summary and Hand In Hand training modules were used in the project data collection.  
The Centers for Medicare and Medicaid provide the BIMS and Mood tools, as part of the 
Minimum Data Set, for the nursing center to evaluate residents.  This tool is done 
electronically and on the intranet within the facility.  BIMS and Mood data was accessed 
and data retrieved using the facility system.  Pharmacy reports are generated monthly by 
the pharmacists providing medications for the facility and distributed to facility 
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Administration.  The administration staff provided copies of six months of Pharmacy 
Review Summaries for the project. 
Data Analysis 
Statistical Package for the Social Sciences (SPSS) version 22 analyzed the 
demographic, cognitive, and mood of each sample.  Data was analyzed by descriptive 
statistics using the paired sample t test. A p value of <.05 was considered significant for 
all tests.  Pharmacy review records from previous reviews and post training reviews were 
analyzed for average and variances.   
Timeline 
At the beginning of October, 2013, the most recent quarterly Brief Interview of 
Mental Status (BIMS) and Pharmacy Review Summaries were collected on the dementia 
patients in the nursing facility.  Implementation of the Hand In Hand training modules 
began in October 2013.  Post training BIMS and Pharmacy Review Summaries were 
collected.  Data was then analyzed using SPSS.  Please refer to Project Timeline in 
Figure 2. 
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Budget 
The following were the costs for the project.  Materials and supplies for the Hand 
In Hand training were available from the nursing facility.   Costs for transportation to the 
facility were incurred; approximately $40 for gas times the training and data collection 
was approximately $200 dollars.  Data collection is already in place through the nursing 
home Brief Interview of Mental Status (BIMS) and Pharmacy Review Summaries.  
Administrative staff were available to run reports.  These are standard reports readily 
available at no additional costs.  A statistician to analyze the data was available at no 
cost. 
Limitations 
  Limitation of this capstone project included sample size of residents with 
dementia and the setting, one nursing home facility.  Potential limitations can also be 
related to accuracy of BIMS data collection from the MDS, due to subjectivity of the 
MDS nurse. A time limitation was also a factor since residents records were analyzed for 
three months of data.  The study would benefit from a larger sample size of dementia 
patients in multiple nursing facilities and a time frame of at least one year. 
Summary 
As costs continue to rise for health care across the United States and the 
population ages, new and innovative ways to manage care, increase quality, and contain 
costs will be essential for all people. Atypical antipsychotics have been shown to increase 
risks, increase costs, and lower the quality of life in the elderly with dementia.  Non-
pharmacological studies have shown some promise in the treatment of dementia.  This 
project was intended to demonstrate that the non-pharmacological Hand In Hand training 
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might potentially modify behaviors and help to reduce the high risk atypical antipsychotic 
use for BPSD. The focus was to confirm the impact that the Hand In Hand intervention 
had on behavior and disseminate the results to medical staff for potential changes to 
medication regimens.  In the future, these implications may help guide atypical 
antipsychotic medication reduction or provide direction for short term medication of 
atypical antipsychotics for dementia residents. 
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CHAPTER IV 
Results 
  The Hand In Hand capstone project was designed to use a non-pharmacological 
training with long-term nursing staff to improve behavior and psychological symptoms in 
dementia (BPSD) residents.  A pre and post chart review was done after training with the 
staff, to evaluate the Brief Interview of Mental Status (BIMS) and mood scoring on 
residents.  Cognitive function and mood are determined in the BIMS tool.  Pharmacy 
Review Summaries were also evaluated to determine changes related to antipsychotic 
medication orders.  The descriptive statistics paired sample t test method was used to 
determine any changes in scores of the BIMS tool. 
Measures 
The Brief Interview of Mental Status (BIMS) measures cognitive patterns with a 
scoring range of 00-15.  The score 99 or four or more 0’s is given by the coder on the 
BIMS tool for any resident unable to complete the questions.  Ranges for scores are 
graded on a scale of: 13-15 indicates cognitive intact function, 8-12 there is moderate 
impairment, and 0-7 indicates severe impairment.  The Mood tool measures in two 
categories i.e. symptom presence and frequency.  The tool scores each side. The 
“presence” side has a total of 0(no) or 1 (yes). The “frequency” score ranges from 0 to 3, 
depending on how many total days the symptoms occur. Together the scores add to a 
range from 00-27.  The lower the score (00) indicates no problem with mood and the 
higher the total score the more indication of increased mood problems.   Residents are 
asked the nine questions concerning  depressed feelings, little interest, poor appetite, 
suicidal thoughts, sleep problems, loss of energy, bad feelings of self, problems with 
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concentration, and noticeable changes in movement or speech.   These are scored on the 
frequency of occurrence.  If the resident is unable or unwilling to respond to the questions 
they receive a 99 or a 4 zero’s score on the Mood tool. 
Sample 
In total, only six (N=6) dementia residents from the Pharmacy Review Summary, 
on residents receiving mood-altering medications, met the inclusion criteria.  Average 
age ranged from 81 to 94 years old, with one (N= 1) male and five (N=5) females.   
Non-respondents 
Fifty (N=50) charts were reviewed for mood altering medications, dementia 
diagnosis, and atypical antipsychotic medications.   Of the charts reviewed, seven (N=7) 
residents were short-term rehabilitation and were discharged and three (N=3) dementia 
residents died during the project.  The residents that did not meet criteria due to a 
depression diagnosis, although they received atypical antipsychotic medications, were a 
total of three (N=3).  Five (N=5) residents with the dementia diagnosis were receiving 
sedative or hypnotics.  Nineteen (N=19) did not meet criteria, either the dementia or 
atypical antipsychotic medication regime, for the project.  There were two (N=2) 
residents receiving the medications for approved diagnosis of schizophrenia and one 
(N=1) had a psychosis that was receiving the atypical antipsychotic medications.  One 
(N=1) resident was receiving atypical antipsychotic medication without any related 
diagnosis.  There were two (N=2) residents who had dementia diagnosis and atypical 
antipsychotic medication but were unable to complete the Brief Interview of Mental 
Status (BIMS) or Mood tool. One (N=1) resident had pre BIMS and Mood but no post 
documentation. Please refer to Table 1. 
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Table 1 
Chart Review of Targeted Sample 
Charts reviewed                                                          50 
Discharged                                                                    7 
Deaths                                                                           3 
Depression Diagnosis                                                   3 
Sedative/Hypnotic Medications                                    5 
Did not meet criteria                                                    19 
Approved diagnosis                                                       3 
No related diagnosis                                                      1 
Unable to complete tool                                                2 
No documentation for Post results                                1 
Total cases utilized   (N)                                               6                                                
               
Pharmacy Review summaries were collected for three months prior to training 
and for three months post training.  The number of residents receiving atypical 
antipsychotic medication was collected for three months prior to training and for three 
month post training.   The numbers were then averaged for pre and post months. 
The project goal for Hand In Hand training was 80% of facility staff.  Training 
took place in the facility over three days and a total of 101 attended out of 175 
employees, (57.7%) attendance.  Direct care nursing staff attendance was 67, (66%) 
attendance.   Other staff members attending made up the 34% of the Hand In Hand 
training classes.  Please refer to Figure 3. 
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Figure 3.  Hand In Hand Training Attendance by Staff 
 
Descriptive Statistics 
  A retrospective chart review was used for pre and post Brief Interview of Mental 
Status (BIMS) and Mood scores for this project.  A paired-samples t-test was conducted 
to compare the intervention of non-pharmacological Hand In Hand training, comparing 
the pre-BIMS and Mood scores and to the post training BIMS and Mood scores.   There 
was a statistical significance between the scores for pre average BIMS (M=7.438, SD= 
4.0975) and post average BIMS score (M = 4.750, SD = 2.3611) scores; t (5) = 3.064, p = 
.028.  The Mean scores may indicate a decrease in cognitive function level based on 
scoring criteria.  The scoring criteria rates 13-15 as cognitive function intact, 8-12 as 
moderate impairment and 0-7 as severe impairment.  The variance in pre and post Mean 
indicate a decrease in scoring.  Please refer to Table 2. 
Although the paired sample size was inadequate for this project, the Mood mean 
scores before and after interventions were calculated as Mean=2.50 and M=.00, t (5) 
=1.464, p=.203.   Mean scores for Mood is not in true value scores but denotes the 
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scoring mechanism of the tool, which is 00-27.  The .00 not being statistical but 
indicating the variance between the pre and post Means.  These results suggest that the 
Hand In Hand non-pharmacological training does not decrease the behavioral or 
psychological symptoms in the elderly dementia residents or mood. 
 
Table 2. 
Results of Pre and Post Average Brief Interview of Mental Status Scores 
PreBIMS PostBIMS 
(N)                            6     (N)                            6 
   Mean                      7.483       Mean                        4.750 
    SD                       4.0975         SD                         2.3611 
      t/df                   (5)=3.064                                          
     p                         .028  
p<.05 for statistical significance 
Major Findings 
Due to the small sample size, these results suggest that the Hand In Hand non-
pharmacological training does not decrease the behavioral or psychological symptoms in 
the elderly dementia residents or mood and cognitive function decreased during the post 
training.  Similar results may not be reflective of a larger population sample.  
The Pharmacy Review Summary report for pre-training intervention and post 
training scores were averaged for three months.   Resident records reviewed for three 
months pre training (July, August, and September) were averaged and revealed that 
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15.866 residents received atypical antipsychotic medications. Post training records for 3 
months (October, November, and December) revealed that 15.773 residents received the 
medications, a difference of .093.  These results show very little change in the use of 
medications, but also do not show an increase in administration of atypical antipsychotic 
medications.  Please refer to Table 3. 
Table 3.  
Pharmacy Review Summary Regarding Use of Atypical Antipsychotic Medications 
Pharmacy Review Summary 
Pre-Pharmacy Record:  (3 months)  Number Receiving 
Atypical Antipsychotics Before Training    
15.2 16.1 16.3 
Post-Pharmacy Record:  (3 months)  Number Receiving 
Atypical Antipsychotics After Training   
 
15 
 
16.2 
 
16 
 
 Record of Patients Reviewed  50 
  
 
Summary 
             The retrospective chart review done on the project produced a small sample size 
for the project.  The small sample did produce statistically significant results using the 
paired sample t test for the Brief Interview of Mental Status but not the Mood scores.  
Pharmacy Review Summary revealed very little difference in atypical antipsychotic 
medication administration for dementia residents.  However, there was no increase in the 
medication administration to the dementia residents post training intervention. 
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CHAPTER V 
Discussion 
The capstone project was to determine relationship of the Hand In Hand 
intervention to a decrease of behavior and psychological symptoms of dementia resident 
in long-term care.  Training was implemented in a long-term care facility with direct care 
staff and pre and post data was collected on the Brief Interview of Mental Status (BIMS) 
and Mood tools from the Minimum Data Sets (MDS).  Descriptive statistical data was 
done using the paired sample t tests on the BIMS and Mood data.  Pharmacy Review 
Summaries were also collected and averaged for pre and post training to determine any 
changes in atypical antipsychotic medication administration. 
Implication of Findings 
Can non-pharmacological intervention training of direct care staff decrease 
behavior and psychological symptoms in elderly dementia residents and potentially 
demonstrate a need for reduction in atypical antipsychotic medication use? 
The project results did show some difference in the mean of pre Brief Interview of 
Mental Status (BIMS) and Mood scores when compared to post scoring.  The BIMS 
mean scores went down, indicating a decrease in the residents cognitive function level.  
The Mood mean scores also went down, although paired sample size was inadequate, and 
might be a possible indication of improved mood in the elderly dementia residents.  One 
finding that was small but important was that the administration of atypical antipsychotic 
medications did not increase from the three months pre training and the three months post 
training, based on the Pharmacy Review Summaries.  This is important in the initiative to 
monitor and decrease the use of these drugs, (Kohen, et al., 2010; Lindsey, 2009).  
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The findings also mirror another project with non-pharmacological treatments; the 
lack of rigorous scientific design (O'Neil et al., 2011).  The project did not have a random 
control design to produce empirical data.   Training tools and evaluation tools from 
Centers for Medicare and Medicaid Services (CMS), which did not produce a cost factor, 
is an area missing in the literature on non-pharmacological treatments.  Due to these tools 
being indicated for use by CMS, this project did not add to the literature on costs. 
Application to Theoretical/Conceptual Framework 
The findings were congruent with the primary, secondary, and tertiary model 
phases of Neuman’s Care Systems Model (Neuman Systems Model, 2013).  The primary 
prevention was on health promotion and the ability of direct care staff to recognize the 
stressors that might trigger behavior and psychological symptoms in dementia residents.  
The Hand In Hand training aided in the secondary line of prevention with a non-
pharmacological intervention to help the resident react to internal and external stressors.  
As the non-pharmacological interventions were implemented and reinforced by staff, the 
tertiary prevention level was executed to help the resident adapt to change and return to a 
wellness state.  Betty Nueman’s Care System Theory was an appropriate framework for 
the interventions utilized to help the residents manage stress, communicate effectively 
and use other methods to help the resident adapt to changes in their environment and 
maintain equilibrium. 
Limitations 
The findings of this project were impacted by the small sample size and limitation 
of one nursing home.  Availability of training time and staff numbers for training also 
influenced the time for data collection.  Unexpected administrative turnover in key areas 
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related to education and data collection, delayed training and collection of data.   
Additional projects with larger sample size, multiple nursing facilities, dementia units, 
and various data collection methods may produce statistical significant outcomes for non-
pharmacological interventions in dementia.   
Another area for consideration is the development of tools for evaluating 
symptoms that capture the data thoroughly, succinctly, and in multiple formats.  
Documented on one Mood tool, the nurse had noted that the resident stated “I can’t hear 
you! Oh just forget it”.  This score then became a 99 because the resident refused to 
complete the questions.  When working with the elderly, nurses need to consider all the 
sensory deficits and design a universal tool to use that works for alternative 
communication needs.    
Implications for Nursing 
The results of this project have significance to nursing for improvement in the 
person-centered care of the elderly dementia resident.  Results have shown a need to 
explore ways to improve the behavior and psychological symptoms in dementia (BPSD) 
through non-pharmacological treatments using educational tools to help direct care staff.   
The findings support the need for non-pharmacological intervention projects designed as 
rigorous scientific methods to capture empirical data.  If a transition to a non-
pharmacological treatment of BSPD is to be achieved, then new protocols and modalities 
of treatment need to be developed and supported by empirical evidence.        
Recommendations 
Additional projects and studies using the implementation of Hand In Hand 
training for direct care staff, on dementia units in multiple facilities, would be helpful in 
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adding to the statistical data.   The need to extend the time frame for the study should 
help to produce more significant data.  Development of diverse tools for sensory deficits 
and random controlled design could support the need for increased usage of non-
pharmacological interventions in dementia care. 
Conclusion 
This project was done to show a correlation between the non-pharmacological 
intervention Hand In Hand training and behaviors and psychological symptoms in elderly 
dementia residents.   The training was completed with 66% of direct care staff within the 
long term nursing center.  Collection of Brief Interview of Mental Status (BIMS) and 
Mood data from the Minimum Data Sets were collected pre and post training and 
descriptive statistics were used to analyze the data.  Although statistical significance was 
shown on the paired sample t test with the BIMS score, there was a decrease on the Mean 
scores for pre and post scores which may denote a decline in cognitive function based on 
the variance between Mean and the tools scoring criteria.  This decrease in Mean mood 
scores indicated a possible improvement after the training.  More rigorous and empirical 
testing is warranted to support conclusive results.  However, the Pharmacy Review 
Summaries did not show any increase in prescriptions for atypical antipsychotic 
treatment for the dementia residents.   The findings may indicate that direct care staff 
used the non-pharmacological training in the daily care of the elderly dementia resident 
and that conservative prescribing of atypical antipsychotic medications are also part of 
the equation.  This project adds to the essential need for more projects and studies in the 
non-pharmacological treatment of behavior and psychological symptoms of dementia in 
elderly residents. 
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Appendix A 
OIG Statistics on Off Label Atypical Antipsychotics Claims  
Generic Name of Drug Claims Dollar Amount 
 
Quetiapine 627,661 $85,847,131 
Risperidone 536,600 $87,161,507 
Olanzapine 356,695 $94,055,067 
Aripiprazole 83,756 $29,565,887 
Ziprasidone 44,681 $10,067,477 
Clozapine 27,294 $1,691,718 
Olanzapine/Fluoxetine 1,521 $431,799 
Paliperidone 666 $207,731 
 
Total Claims Costs 
 1,678,874 $309,028,317 
 
Source: (OIG Report, 2011) 
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Appendix B 
Claims for Medicare of Atypical Antipsychotics (Number/Percentage) 
 
Claim for drug indication Number Percentage 
 
For off-label conditions 1,197,442 83.1% 
In condition presence 
specific to FDA box 
warning 
1,263,641 87.7% 
Off-label conditions and 
with FDA warning 
1,088,260 75.5% 
Off-label conditions and/or 
specific FDA warnings 
1,372,823 95.3% 
Neither off-label or specific 
FDA box warning 
conditions present 
68,277 4.7% 
 
Total (net) 1,441,100* 100% 
Records that were not 
reviewed 
237,744 n/a 
Total Claims 1,678,874 n/a 
 
 
 
Source: (OIG Report, 2011) 
*Projection is based on reviewed records only and do not reflect size of population in  
Appendix A 
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Appendix C 
Invalid Medicare Claims 
 
 
Error Reasons Number Percentages Dollar Amount 
 
Drug claimed was 
not documented* 
3,808 0.3% $559,333 
Drug claimed was 
not for medically 
accepted use 
722,975 50.2% $115,919,685 
 
Total errors 726,783 50.5% $116,479,018 
 
Source: (OIG Report, 2011) 
*Undocumented claims for table completion.  Three were undocumented which was too 
low for 95% confidence interval statistically. 
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Appendix D 
Unnecessary Medical Claims by CMS Standards 
 
Reasons for not 
meeting CMS 
Standards 
Number Percentage Dollar Amount 
 
 
Excessive dosage 150,106 10.4% $36,050,851 
Excessive time 135,199 9.4% $29,369,213 
No adequate 
indicator for use 
115,818 8.0% $21,396,226 
No adequate 
monitoring 
110,949 7.7% $18,150,616 
Adverse effects 
present requiring a 
lower or termination 
of drug 
67,923 4.7% $11,479,869 
 
Total (gross*) 579,994 40.2% $116,446,775 
Overlapping 262,023 18.2% $53,251,792 
Total (net) 317,971 22.1% $63,194,984 
 
Source: (OIG Report, 2011) 
*Sums not exact due to rounding of numbers 
 
 
 
